The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
Open accessAbstract
Cardiac hypertrophy is an adaptive and compensatory mechanism preserving cardiac output during detrimental stimuli. Nevertheless, long-term stimuli incite chronic hypertrophy and may lead to heart failure. In this review, we analyze the recent literature regarding the role of ERK (extracellular signal-regulated kinase) activity in cardiac hypertrophy. ERK signaling produces beneficial effects during the early phase of chronic pressure overload in response to G protein-coupled receptors (GPCRs) and integrin stimulation. These functions comprise (i) adaptive concentric hypertrophy and (ii) cell death prevention. On the other hand, ERK participates in maladaptive hypertrophy during hypertension and chemotherapy-mediated cardiac side effects. Specific ERK-associated scaffold proteins are implicated in either cardioprotective or detrimental hypertrophic functions. Interestingly, ERK phosphorylated at threonine 188 and activated ERK5 (the big MAPK 1) are associated with pathological forms of hypertrophy. Finally, we examine the connection between ERK activation and hypertrophy in (i) transgenic mice overexpressing constitutively activated RTKs (receptor tyrosine kinases), (ii) animal models with mutated sarcomeric proteins characteristic of inherited hypertrophic cardiomyopathies (HCMs), and (iii) mice reproducing syndromic genetic RASopathies. Overall, the scientific literature suggests that during cardiac hypertrophy, ERK could be a “good” player to be stimulated or a “bad” actor to be mitigated, depending on the pathophysiological context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,436
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
WIDMANN, C., GIBSON, S., JARPE, M. B., & JOHNSON, G. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.143 · Cited by 2,729
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,065
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds
Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041604898 · Cited by 831
Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals
Morrison, D. K., & Davis, R. J. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111401.091942 · Cited by 786
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759
Prognostic implications of left ventricular hypertrophy
Vakili, B. A., Okin, P. M., & Devereux, R. B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113218 · Cited by 712
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Pandit, B., Sarkozy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., Pogna, E. A., Schackwitz, W., Ustaszewska, A., Landstrom, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2073 · Cited by 698
Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Kehat, I., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.110.942268 · Cited by 592
Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Reiter, E., Ahn, S., Shukla, A. K., & Lefkowitz, R. J. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105800 · Cited by 583
Molecular basis of physiological heart growth: fundamental concepts and new players
Maillet, M., van Berlo, J. H., & Molkentin, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3495 · Cited by 536
Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK
Allan, L. A., Morrice, N., Brady, S., Magee, G., Pathak, S., & Clarke, P. R. (2003) · Nature Cell Biology · doi:10.1038/ncb1005 · Cited by 474
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 418
Genetic Basis of Hypertrophic Cardiomyopathy: From Bench to the Clinics
ALCALAI, R., SEIDMAN, J. G., & SEIDMAN, C. E. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00965.x · Cited by 387
Paradis, P., Dali-Youcef, N., Paradis, F. W., Thibault, G., & Nemer, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.931 · Cited by 382
Patel, R., Nagueh, S. F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H. A., Quinones, M. A., Zoghbi, W. A., Entman, M. L., Roberts, R., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.317 · Cited by 357
Primary Structure of BMK1: A New Mammalian MAP Kinase
Lee, J. D., Ulevitch, R. J., & Han, J. H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2189 · Cited by 342
MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors
Tran, S. E. F., Holmström, T. H., Ahonen, M., Kähäri, V.-M., & Eriksson, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010384200 · Cited by 330
Domina, A. M., Vrana, J. A., Gregory, M. A., Hann, S. R., & Craig, R. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207692 · Cited by 327
Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking
Miller, W. E., & Lefkowitz, R. J. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00190-3 · Cited by 322
Mitogen-Activated Protein Kinases in Heart Development and Diseases
Wang, Y. (2007) · Circulation · doi:10.1161/circulationaha.106.679589 · Cited by 315
The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans
Kornfeld, K., Hom, D. B., & Horvitz, H. R. (1995) · Cell · doi:10.1016/0092-8674(95)90206-6 · Cited by 299
Brancaccio, M., Fratta, L., Notte, A., Hirsch, E., Poulet, R., Guazzone, S., De Acetis, M., Vecchione, C., Marino, G., Altruda, F., et al. (2003) · Nature Medicine · doi:10.1038/nm805 · Cited by 296
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296
Genetic Dissection of Cardiac Growth Control Pathways
MacLellan, W. R., & Schneider, M. D. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.289 · Cited by 289
Suzuki, J., Matsubara, H., Urakami, M., & Inada, M. (1993) · Circulation Research · doi:10.1161/01.res.73.3.439 · Cited by 283
Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy
Nicol, R. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2757 · Cited by 281
β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276
Hayakawa, J., Ohmichi, M., Kurachi, H., Kanda, Y., Hisamoto, K., Nishio, Y., Adachi, K., Tasaka, K., Kanzaki, T., & Murata, Y. (2000) · PubMed · Cited by 274
Liang, Q., Wiese, R. J., Bueno, O. F., Dai, Y.-S., Markham, B. E., & Molkentin, J. D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.21.7460-7469.2001 · Cited by 271
Sheikh, F., Raskin, A., Chu, P.-H., Lange, S., Domenighetti, A. A., Zheng, M., Liang, X., Zhang, T., Yajima, T., Gu, Y., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34472 · Cited by 251
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Rochette, L., Guenancia, C., Gudjoncik, A., Hachet, O., Zeller, M., Cottin, Y., & Vergely, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.005 · Cited by 248
A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy
Davis, J., Davis, L. C., Correll, R. N., Makarewich, C. A., Schwanekamp, J. A., Moussavi-Harami, F., Wang, D., York, A. J., Wu, H., Houser, S. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.002 · Cited by 248
Purcell, N. H., Wilkins, B. J., York, A., Saba-El-Leil, M. K., Meloche, S., Robbins, J., & Molkentin, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610906104 · Cited by 246
Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in Rats
Kim, S., Ohta, K., Hamaguchi, A., Yukimura, T., Miura, K., & Iwao, H. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1252 · Cited by 246
Fukazawa, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.012 · Cited by 238
Wu, X., Simpson, J., Hong, J. H., Kim, K.-H., Thavarajah, N. K., Backx, P. H., Neel, B. G., & Araki, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44929 · Cited by 234
Protein scaffolds in MAP kinase signalling
Brown, M. D., & Sacks, D. B. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.11.013 · Cited by 224
Essential Roles of Her2/erbB2 in Cardiac Development and Function
Negro, A. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.1 · Cited by 220
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
Lorenz, K., Schmitt, J. P., Schmitteckert, E. M., & Lohse, M. J. (2009) · Nature Medicine · doi:10.1038/nm.1893 · Cited by 220
O’Connell, T. D., Ishizaka, S., Nakamura, A., Swigart, P. M., Rodrigo, M. C., Simpson, G. L., Cotecchia, S., Rokosh, D. G., Grossman, W., Foster, E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16100 · Cited by 205
Cardiac GPCRs: GPCR signaling in healthy and failing hearts
Salazar, N. C., Chen, J., & Rockman, H. A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.010 · Cited by 205
Harada, K., Sugaya, T., Murakami, K., Yazaki, Y., & Komuro, I. (1999) · Circulation · doi:10.1161/01.cir.100.20.2093 · Cited by 201
Hariharan, R., Alberg, C., Sagoo Gurdeep, S., Hilary, B., Behr Elijah, R., 奚卉, & 杜昕 (2012) · doi:10.3760/cma.j.issn.1007-9742.2012.01.138 · Cited by 197
Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence
Selvetella, G., HIRSCH, E., Notte, A., Tarone, G., & LEMBO, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.031 · Cited by 189
Integrin signalling: The tug-of-war in heart hypertrophy
BRANCACCIO, M., HIRSCH, E., NOTTE, A., SELVETELLA, G., LEMBO, G., & TARONE, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.015 · Cited by 188
Towbin, J. A. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0893 · Cited by 185
Harris, I. S., Zhang, S., Treskov, I., Kovacs, A., Weinheimer, C., & Muslin, A. J. (2004) · Circulation · doi:10.1161/01.cir.0000138190.50127.6a · Cited by 177
Ahn, S., Wei, H., Garrison, T. R., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300443200 · Cited by 177
Kagiyama, S., Eguchi, S., Frank, G. D., Inagami, T., Zhang, Y. C., & Phillips, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000030181.63741.56 · Cited by 176
Biswas, S. C., & Greene, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208086200 · Cited by 174
Zhai, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25330 · Cited by 171
Roles of FGF Signals in Heart Development, Health, and Disease
Itoh, N., Ohta, H., Nakayama, Y., & Konishi, M. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00110 · Cited by 163
Rockman, H. A., Wachhorst, S. P., Mao, L., & Ross, J. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2468 · Cited by 160
Trastuzumab cardiotoxicity: from clinical trials to experimental studies
Németh, B. T., Varga, Z. V., Wu, W. J., & Pacher, P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13643 · Cited by 151
Mohan, N., Shen, Y., Endo, Y., ElZarrad, M. K., & Wu, W. J. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0741 · Cited by 137
Kobayashi, T., Aoki, Y., Niihori, T., Cavé, H., Verloès, A., Okamoto, N., Kawame, H., Fujiwara, I., Takada, F., Ohata, T., et al. (2010) · Human Mutation · doi:10.1002/humu.21187 · Cited by 136
Petrich, B. G., & Wang, Y. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.11.002 · Cited by 132
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
Lou, H., Danelisen, I., & Singal, P. K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01054.2004 · Cited by 115
IEX‐1: a new ERK substrate involved in both ERK survival activity and ERK activation
Garcia, J., Ye, Y., Arranz, V., Letourneux, C., Pézeron, G., & Porteu, F. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf488 · Cited by 112
In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice
Gerits, N., Kostenko, S., & Moens, U. L. (2007) · Transgenic Research · doi:10.1007/s11248-006-9052-0 · Cited by 107
Acetis, M. D., Notte, A., Accornero, F., Selvetella, G., Brancaccio, M., Vecchione, C., Sbroggió, M., Collino, F., Pacchioni, B., Lanfranchi, G., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000168028.36081.e0 · Cited by 105
Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy
Higgins, E. M., Bos, J. M., Mason‐Suares, H., Tester, D. J., Ackerman, J. P., MacRae, C. A., Sol‐Church, K., Gripp, K. W., Urrutia, R. A., & Ackerman, M. J. (2017) · JCI Insight · doi:10.1172/jci.insight.91225 · Cited by 100
Kontaridis, M. I., Yang, W., Bence, K. K., Cullen, D., Wang, B., Bodyak, N. D., Ke, Q., Hinek, A., Kang, P. M., Liao, R., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728865 · Cited by 94
Role of the renin-angiotensin system in cardiac hypertrophy
Yamazaki, T., Komuro, I., & Yazaki, Y. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00259-3 · Cited by 93
Robinson, P. J., Liu, X., Sparrow, A. J., Patel, S. D., Zhang, Y. H., Casadei, B., Watkins, H. C., & Redwood, C. S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002081 · Cited by 87
Ruppert, C., Deiss, K., Herrmann, S., Vidal, M., Oezkur, M., Gorski, A., Weidemann, F., Lohse, M. J., & Lorenz, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221999110 · Cited by 86
Li, X., Ma, Y., Yang, Y., Liu, F., Chen, B., Han, W., Zhang, J., & Gao, X. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05243.x · Cited by 79
Zhong, L., Chiusa, M., Cadar, A. G., Lin, A. M., Samaras, S. E., Davidson, J. M., & Lim, C. C. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv108 · Cited by 79
Cardiac mechanotransduction: from sensing to disease and treatment
Tavi, P., Laine, M., Weckström, M., & Ruskoaho, H. J. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01679-5 · Cited by 73
Schreier, B., Rabe, S., Schneider, B., Bretschneider, M., Rupp, S., Ruhs, S., Neumann, J., Rueckschloss, U., Sibilia, M. C., Gotthardt, M., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196543 · Cited by 71
Doxorubicin and Trastuzumab Regimen Induces Biventricular Failure in Mice
Milano, G., Raucci, A., Scopece, A., Daniele, R., Guerrini, U., Sironi, L., Cardinale, D. M., Capogrossi, M. C., & Pompilio, G. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.01.014 · Cited by 69
Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
Peng, K., Tian, X., Qian, Y., Skibba, M. E., Zou, C., Liu, Z., Wang, J., Xu, Z., Li, X., & Liang, G. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12763 · Cited by 65
Sysa‐Shah, P., Yi, X., Guo, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042805 · Cited by 64
Bang, M., Gu, Y., Dalton, N. D., Peterson, K. L., Chien, K. R., & Chen, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093638 · Cited by 62
Eccentric cardiac hypertrophy was induced by long‐term intermittent hypoxia in rats
Chen, L., Kuo, W., Yang, J., Wang, S.-G. P., Yeh, Y., Tsai, F., Ho, Y., Chang, M., Huang, C., & Lee, S. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.036590 · Cited by 60
Huang, C., Chen, J., Kuo, C., Pai, P., Ho, T., Chen, T., Tsai, F., Padma, V. V., Kuo, W., & Huang, C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25905 · Cited by 56
Signaling to Cardiac Hypertrophy: Insights from Human and Mouse RASopathies
Sala, V., Gallo, S., Leo, C., Gatti, S., Gelb, B. D., & Crepaldi, T. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00512 · Cited by 53
Self-citationBeta-Arrestin-Mediated Signaling in the Heart
Patel, P. A., Tilley, D. G., & Rockman, H. A. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0734 · Cited by 52
Cilvik, S. N., Wang, J. I., Lavine, K. J., Uchida, K., Castro, A., Gierasch, C. M., Weinheimer, C. J., House, S. L., Kovács, A. D., Nichols, C. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082979 · Cited by 50
Cameron, S. J., Itoh, S., Baines, C. P., Zhang, C., Ohta, S., Che, W., Glassman, M., Lee, J.-D., Chen, Y., Yang, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.120 · Cited by 50
Mutlak, M., Schlesinger−Laufer, M., Haas, T., Shofti, R., Ballan, N., Lewis, Y. E., Zuler, M., Zohar, Y., Caspi, L. H., & Kehat, I. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.068 · Cited by 43
Molecular Mechanisms of Cardiac Hypertrophy Induced by Toxicants
Chen, Q. M., Tu, V. C., Purdom, S., Wood, J. R., & Dilley, T. (2001) · Cardiovascular Toxicology · doi:10.1385/ct:1:4:267 · Cited by 42
Tang, F., Zhou, X., Wang, L., Shan, L., Li, C., Zhou, H., Lee, S. M., & Hoi, M. P. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.021 · Cited by 42
He, S., Jin, S., Wu, H., Wang, B., Yun-xiang, W., Zhang, S., Irwin, M. G., Wong, T., & Zhang, Y. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.08.007 · Cited by 41
Pires, K. M. P., Buffolo, M., Schaaf, C., Symons, J. D., Cox, J. E., Abel, E. D., Selzman, C. H., & Boudina, S. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.10.001 · Cited by 41
The function of Shoc2: A scaffold and beyond
Jang, E. R., & Galperin, E. (2016) · Communicative & Integrative Biology · doi:10.1080/19420889.2016.1188241 · Cited by 39
Met signaling in cardiomyocytes is required for normal cardiac function in adult mice
Arechederra, M., Carmona, R., González-Núñez, M., Gutiérrez-Uzquiza, Á., Bragado, P., Cruz‐González, I., Cano, E., Guerrero, C., Sánchez, A., López-Novoa, J. M., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.008 · Cited by 36
Erbin is a negative modulator of cardiac hypertrophy
Rachmin, I., Tshori, S., Smith, Y., Oppenheim, A., Marchetto, S., Kay, G., Foo, R., Dagan, N., Golomb, E., Gilon, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320350111 · Cited by 35
Morgana and melusin: Two fairies chaperoning signal transduction
Ferretti, R., Sbroggió, M., Savino, A. D., Fusella, F., Bertero, A., Michowski, W., Tarone, G., & Brancaccio, M. (2011) · Cell Cycle · doi:10.4161/cc.10.21.18202 · Cited by 28
Liang, Y., & Sheikh, F. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00037 · Cited by 27
Li, C., Chen, Z., Yang, H., Luo, F., Chen, L., Cai, H., Li, Y., You, G., Long, D., Li, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159079 · Cited by 26
Hasinoff, B. B., Patel, D., & Wu, X. (2012) · Cardiovascular Toxicology · doi:10.1007/s12012-012-9183-x · Cited by 23
Analyzing ERK 1/2 signalling and targets
Brietz, A., Schuch, K. V., Wangorsch, G., Lorenz, K., & Dandekar, T. (2016) · Molecular BioSystems · doi:10.1039/c6mb00255b · Cited by 20
Sala, V., Gallo, S., Gatti, S., Médico, E., Vigna, E., Cantarella, D., Fontani, L., Natale, M., Cimino, J. J., Morello, M., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.02.017 · Cited by 19
Self-citationZhao, Z., Wang, W., Geng, J., Wang, L., Su, G., Zhang, Y., Ge, Z., & Kang, W. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22441 · Cited by 18
Yeh, C., Fan, Y., Xu, Y., Yang, Y., Simpson, P. C., & Mann, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188471 · Cited by 14
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Target Sestrin2 to rescue the damaged organ: mechanistic insight into its function
Ala, M., & Eftekhar, S. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8790369 · Cited by 27
Metadata
- Authors
- Gallo, S., Vitacolonna, A., Bonzano, A., Comoglio, P., & Crepaldi, T.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-05-01
- Volume
- 20
- Issue
- 9
- Pages
- 2164
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2943156153
- Cited by
- 264
- References
- 105
- FWCI
- 20.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.